Atlas Trials

Abeona Therapeutics, Inc

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Abeona Therapeutics, Inc

RecordFirmDate
Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds (NCT07717736)Abeona Therapeutics, Inc2026-11-01
A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting (NCT07700966)Abeona Therapeutics, Inc2025-07-25
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients (NCT05725018)Abeona Therapeutics, Inc2023-04-02
A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB (NCT05708677)Abeona Therapeutics, Inc2021-02-09
A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101 (NCT04655911)Abeona Therapeutics, Inc2020-10-28
Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) (NCT04227106)Abeona Therapeutics, Inc2020-01-10
Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB (NCT03315182)Abeona Therapeutics, Inc2017-10-16

Track Abeona Therapeutics, Inc automatically

Every clearance here is in the API, with alerts when new ones post.